K922701

Substantially Equivalent

DU PONT ACA PLUS IMMUNOASSAY SYSTEM TSH METHOD

Applicant: E.I. Dupont DE Nemours & Co., Inc.
Product code: JLW
Advisory panel: Clinical Chemistry
Date received: 1992-06-04
Decision date: 1992-09-09
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Wilmington, DE, US

Adverse events under product code JLW

product code JLW

Malfunction: 885
Total: 885

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.